Literature DB >> 26025724

Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Assessed by Echocardiography Predicts Adverse Clinical Outcome.

Thomas P Mast1, Arco J Teske2, Jeroen F vd Heijden1, Judith A Groeneweg1, Anneline S J M Te Riele1, Birgitta K Velthuis3, Richard N W Hauer4, Pieter A Doevendans1, Maarten J Cramer1.   

Abstract

BACKGROUND: Among studies describing the phenotype of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), significant discrepancy exists regarding the extent and impact of left ventricular (LV) involvement. The capability of conventional and new quantitative echocardiographic techniques to accurately detect LV involvement in ARVD/C remains unknown. The aim of this study was to test the hypothesis that accurate detection of LV involvement on echocardiography identifies patients at additional risk for cardiac events during follow-up.
METHODS: Thirty-eight patients with ARVD/C, 16 pathogenic mutation-positive relatives, and 55 healthy control subjects were prospectively enrolled. Conventional echocardiography with additional deformation imaging was performed in all subjects to detect LV involvement. In a subgroup (n = 27), cardiac magnetic resonance imaging was performed with late enhancement. All patients and relatives were prospectively followed for events (sustained ventricular tachycardia, appropriate implantable cardioverter-defibrillator intervention, sudden cardiac death, and heart transplantation).
RESULTS: Conventional echocardiography detected LV involvement in 32% of patients with ARVD/C and in none of the relatives. Deformation imaging revealed LV involvement in 68% of patients with ARVD/C and 25% of relatives and was correlated closely with late enhancement on cardiac magnetic resonance imaging. During a mean follow-up period of 5.9 ± 2.3 years, 20 patients with ARVD/C (53%) experienced events, and no events occurred in the relatives. LV involvement detected by deformation imaging (hazard ratio, 4.9; 95% CI, 1.7-14.2) and right ventricular outflow tract enlargement (hazard ratio, 1.2; 95% CI, 1.1-1.3) were the only independent predictors of outcomes.
CONCLUSIONS: Deformation imaging detected a high incidence of LV involvement in patients with ARVD/C and their relatives. Compared with conventional echocardiography, deformation imaging is superior in detecting minor LV involvement. LV involvement and an enlarged right ventricular outflow tract are independent prognostic markers of outcomes.
Copyright © 2015 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARVD/C; Arrhythmogenic right ventricular cardiomyopathy; Deformation imaging; Echocardiography; LV involvement; Prognosis

Mesh:

Year:  2015        PMID: 26025724     DOI: 10.1016/j.echo.2015.04.015

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  11 in total

Review 1.  Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.

Authors:  Ali J Marian; Eva van Rooij; Robert Roberts
Journal:  J Am Coll Cardiol       Date:  2016-12-27       Impact factor: 24.094

2.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

3.  Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Authors:  Deniz Akdis; Corinna Brunckhorst; Firat Duru; Ardan M Saguner
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 4.  Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance.

Authors:  Victoria Delgado; Chiara Bucciarelli-Ducci; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2016-07-29       Impact factor: 5.952

Review 5.  Arrhythmogenic Right Ventricular Dysplasia in Neuromuscular Disorders.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Med Insights Cardiol       Date:  2016-10-19

6.  Early Left Ventricular Involvement Detected by Cardiovascular Magnetic Resonance Feature Tracking in Arrhythmogenic Right Ventricular Cardiomyopathy: The Effects of Left Ventricular Late Gadolinium Enhancement and Right Ventricular Dysfunction.

Authors:  Xiuyu Chen; Lu Li; Huaibin Cheng; Yanyan Song; Keshan Ji; Lin Chen; Tongtong Han; Minjie Lu; Shihua Zhao
Journal:  J Am Heart Assoc       Date:  2019-08-23       Impact factor: 5.501

7.  Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Predicts Adverse Clinical Outcomes: A Cardiovascular Magnetic Resonance Feature Tracking Study.

Authors:  Meng-Ting Shen; Zhi-Gang Yang; Kai-Yue Diao; Li Jiang; Yi Zhang; Xi Liu; Yue Gao; Bi-Yue Hu; Shan Huang; Ying-Kun Guo
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

Review 8.  How to interpret right ventricular remodeling in athletes.

Authors:  María Sanz-de la Garza; Amelia Carro; Stefano Caselli
Journal:  Clin Cardiol       Date:  2020-03-04       Impact factor: 2.882

9.  The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.

Authors:  Leila Rouhi; Siyang Fan; Sirisha M Cheedipudi; Aitana Braza-Boïls; Maria Sabater Molina; Yan Yao; Matthew J Robertson; Cristian Coarfa; Juan R Gimeno; Pilar Molina; Priyatansh Gurha; Esther Zorio; Ali J Marian
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

10.  Characteristics and prognostic implications of tricuspid regurgitation in patients with arrhythmogenic cardiomyopathy.

Authors:  Hyeonju Jeong; Shinjeong Song; Jiwon Seo; Iksung Cho; Geu-Ru Hong; Jong-Won Ha; Chi Young Shim
Journal:  ESC Heart Fail       Date:  2020-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.